Conditions: Brain Metastases
Interventions: Drug: Glucocorticoids
Sponsors: Medical University of Vienna
Completed
Feeds
18700 items (18700 unread) in 74 feeds
Acinar Cell Carcinoma
(280 unread)
Acinic Cell Carcinoma
(164 unread)
Adenoid Cystic Carcinoma
(287 unread)
Adrenal Gland Cancer
(1320 unread)
Ampulla Of Vater
(276 unread)
Anal Cancer
(1430 unread)
Angiosarcoma
(544 unread)
Appendix Cancer
(397 unread)
Bile Duct Cancer
(2525 unread)
Brain and CNS
(3891 unread)
Carcinoid
(468 unread)
Endocrine/Neuroendocrine
(3166 unread)
Gall Bladder Cancer
(691 unread)
Hemangioendothelioma
(614 unread)
Hepatoblastoma
(434 unread)
Pancreas
(281 unread)
Phyllodes
(164 unread)
PMP and Mucinous Tumors
(239 unread)
Rhabdomyosarcoma
(622 unread)
Sarcoma
(907 unread)
Trial - Brain Tumor (6 unread)
-
Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases
Posted: August 1st, 2019, 2:00am GMT
-
MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients
Posted: July 25th, 2019, 2:00am GMT
Conditions: Cognitive Impairment, Mild; Cognitive Dysfunction; Amyloid Plaque; Neurodegeneration; Inflammation, Brain
Interventions: Drug: Lenalidomide 10 mg; Drug: Placebo
Sponsors: St. Joseph's Hospital and Medical Center, Phoenix; National Institute on Aging (NIA); The Cleveland Clinic
Recruiting -
Biologic Mechanisms of Early Exercise After Intracerebral Hemorrhage
Posted: July 19th, 2019, 2:00am GMT
Conditions: Intracerebral Hemorrhage; Acute Ischemic Stroke
Interventions: Device: Supine cycle ergometry of the lower extremities
Sponsors: Johns Hopkins University
Completed -
Impact of Insomnia Treatment on Brain Responses During Resting-state and Cognitive Tasks
Posted: July 18th, 2019, 2:00am GMT
Conditions: Chronic Insomnia
Interventions: Behavioral: Cognitive-Behavioural therapy for insomnia (CBT-I)
Sponsors: Concordia University, Montreal; Canadian Institutes of Health Research (CIHR)
Recruiting -
Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma
Posted: July 17th, 2019, 2:00am GMT
Conditions: Brain and Nervous System; Eye and Orbit
Interventions: Drug: Nivolumab
Sponsors: Wake Forest University Health Sciences; Bristol-Myers Squibb; Atrium Health Levine Cancer Institute
Active, not recruiting -
Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors
Posted: July 15th, 2019, 2:00am GMT
Conditions: Brain Tumor, Pediatric
Sponsors: Capital Medical University
Withdrawn